Slideshow

How Safe is Long-term Antiplatelet Rx After a Vascular Event?

Author(s):

Veronica Hackethal, MD

Here is new evidence that people aged 75 and older who take aspirin-based antiplatelet treatment for secondary prevention should also take PPIs.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Elizabeth Seng, PhD
Kevin Sheth, MD
Kara R. Melmed, MD
Roy H. Hamilton, MD, MS, FAAN
Chitra Venkatasubramanian, MBBS, MD, MSc, FNCS
Roy H. Hamilton, MD, MS, FAAN
Related Content
Flat Head Positioning Before Thrombectomy Linked to Better Long-Term Stroke Outcomes
July 9th 2025

Flat Head Positioning Before Thrombectomy Linked to Better Long-Term Stroke Outcomes

Marco Meglio
Episode 145: Rewiring Stroke Recovery: What the Glymphatic System Can Teach Us
July 11th 2025

Episode 145: Rewiring Stroke Recovery: What the Glymphatic System Can Teach Us

Marco Meglio Joyce Lee-Iannotti, MD, FAAN, FAASM
Most Impactful Neurology Trial Readouts From Early 2025
June 30th 2025

Most Impactful Neurology Trial Readouts From Early 2025

Marco Meglio Isabella Ciccone, MPH
Special Episode: FDA Approves Tenecteplase for Acute Ischemic Stroke
March 12th 2025

Special Episode: FDA Approves Tenecteplase for Acute Ischemic Stroke

Marco Meglio
Understanding the Evolving Care of Rehabilitation and Stroke Recovery
June 1st 2025

Understanding the Evolving Care of Rehabilitation and Stroke Recovery

Francois Bethoux, MD Andrew Russman, DO Mark Bain, MD
From Neurology Enthusiast to Advocate for Health Equity: Moira Kapral’s SEQUINS Hall of Fame Journey
May 1st 2025

From Neurology Enthusiast to Advocate for Health Equity: Moira Kapral’s SEQUINS Hall of Fame Journey

Marco Meglio
© 2025 MJH Life Sciences

All rights reserved.